Active Digestion, Kidneys & Other Organs Cancer

Biological validation of human liver somatic mutations

In plain English

AI plain-English summary

The liver’s ability to regrow after injury depends on specific genes that allow liver cells to multiply, but scientists do not yet know which genes control this process or how they work together. This project aims to fill that gap. The researcher will compare healthy livers with those damaged by end-stage disease, looking for genetic changes that drive regeneration. Using stem cells grown into liver cells in the lab, they will test how different genes interact to control cell division. The work is fundamental science—it seeks to understand the basic molecular machinery of liver repair, not to test a treatment tomorrow. If successful, the research could eventually lead to new therapies for liver disease. Understanding the genetic switches that trigger regeneration might allow scientists to grow replacement liver cells in the laboratory for transplantation, or to design drugs that stimulate the liver to repair itself in patients with cirrhosis. These applications are years away, but the same kind of fundamental genetic work has previously unlocked treatments for other chronic diseases.

View original technical description
It is well known that the liver is an organ with extraordinary capacity for regeneration and repair. However we do not understand many of the basic mechanisms by which this occurs and what regulates the growth following injury. Our previous work has shown that certain genes seem to play an important role in enabling liver cells (hepatocytes) to divide and form large groups of cells. My approach is to study what happens in healthy and end stage liver disease in order to identify key genes which are involved in liver regeneration. I will then use a variety of novel scientific techniques, such as stem cell derived hepatocytes to unravel the complex relationship between these different genetic pathways. By understanding what goes on at the molecular and cellular level, we will ultimately be able to design new treatments for liver disease such as growing liver cells in the laboratory for cell therapies or by developing new drugs to combat cirrhosis.

View the original record at the funder ↗

Researchers

Foad Jafari Rouhani (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

A single-cell sequencing approach to identify new therapeutic targets to drive liver regeneration
Genome-wide screening for genes regulating mouse CLiPs self-renewal and differentiation using CRISPR-Cas9
The role of tumour necrosis factor superfamily receptors and the innate immune system in liver inflammation and epithelial to mesenchymal transition
Mechanisms controlling hepatoblast specification during human development
Modelling liver fibrosis using human Induced Pluripotent Stem Cells.

Original classification

Fellowship

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.